Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Apr;45(4):348-51.
doi: 10.1136/jcp.45.4.348.

Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia

M Uguccioni  1 , R Meliconi, E Lalli, S Nesci, C Delfini, G Lucarelli, G Gasbarrini, A Facchini
Affiliations

Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia

M Uguccioni et al. J Clin Pathol. 1992 Apr.

Abstract

Aims: To investigate whether serum amyloid A protein (SAA) and C-reactive protein (CRP) concentrations could be used in the management of beta thalassaemic patients undergoing bone marrow transplantation (BMT).

Methods: Serum SAA and CRP concentrations were determined in paired samples from 66 patients with beta thalassaemia before and after BMT. Serum SAA concentrations were determined by an enzyme linked immunoassay (EIA); serum CRP concentrations were determined by a nephelometric assay.

Results: Serum SAA concentrations before transplantation were significantly higher in the group that subsequently rejected the transplant than the group without complications. SAA concentrations increased after BMT in acute graft versus host disease (GvHD) and rejection. No significant increase in SAA or CRP was found in chronic GvHD. Increases in serum in SAA and CRP concentrations were not related to concomitant infection episodes.

Conclusions: The different acute phase response in acute GvHD and rejection compared with chronic GvHD suggests that different immunopathogenic mechanisms are responsible.

PubMed Disclaimer

References

    1. J Immunol Methods. 1986 Aug 21;92(1):37-43 - PubMed
    1. N Engl J Med. 1975 Apr 24;292(17):895-902 - PubMed
    1. J Immunol Methods. 1985 Nov 7;83(2):217-25 - PubMed
    1. N Engl J Med. 1990 Feb 15;322(7):417-21 - PubMed
    1. J Clin Pathol. 1984 Mar;37(3):263-6 - PubMed